{"transactions":[{"id":1375707,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":1,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":2,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":3,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":4,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":7,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":8,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":9,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T15:08:23.000Z","date":"2024-11-01","kind":"purchase","planned":false,"acquired":true,"shares":877,"price":3.75,"value":3288.75,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VI"},"balance_after":22479,"source":{"system":"sec-edgar","filing":"0001415889-24-026103","document":"form4-11052024_081117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924026103/form4-11052024_081117.xml","form_type":"4"}},{"id":1375706,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":1,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":2,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":3,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":4,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":7,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":8,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":9,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T15:08:23.000Z","date":"2024-11-01","kind":"purchase","planned":false,"acquired":true,"shares":86867,"price":3.75,"value":325751.25,"ownership":{"direct":true},"balance_after":814300,"source":{"system":"sec-edgar","filing":"0001415889-24-026103","document":"form4-11052024_081117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924026103/form4-11052024_081117.xml","form_type":"4"}},{"id":1671146,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":14372,"price":0.125,"value":1796.5,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VII"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."}],"balance_after":14372,"derivative":{"exercise_price":7.15,"exercise_date":"2024-01-23","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":14372},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671145,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":14372,"price":0.125,"value":1796.5,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VII"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."}],"balance_after":14372,"derivative":{"exercise_price":5.36,"exercise_date":"2024-01-23","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":14372},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671144,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":1960,"price":0.125,"value":245.0,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VI"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."}],"balance_after":1960,"derivative":{"exercise_price":7.15,"exercise_date":"2024-01-23","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":1960},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671143,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":1960,"price":0.125,"value":245.0,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VI"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."}],"balance_after":1960,"derivative":{"exercise_price":5.36,"exercise_date":"2024-01-23","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":1960},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671142,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":6592,"price":0.125,"value":824.0,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII Annex Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."}],"balance_after":6592,"derivative":{"exercise_price":7.15,"exercise_date":"2024-01-23","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":6592},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671141,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":6592,"price":0.125,"value":824.0,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII Annex Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."}],"balance_after":6592,"derivative":{"exercise_price":5.36,"exercise_date":"2024-01-23","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":6592},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671140,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":25516,"price":0.125,"value":3189.5,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII (Canada), L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."}],"balance_after":25516,"derivative":{"exercise_price":7.15,"exercise_date":"2024-01-23","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":25516},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671139,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":25516,"price":0.125,"value":3189.5,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII (Canada), L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."}],"balance_after":25516,"derivative":{"exercise_price":5.36,"exercise_date":"2024-01-23","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":25516},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671138,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":97236,"price":0.125,"value":12154.5,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."}],"balance_after":97236,"derivative":{"exercise_price":7.15,"exercise_date":"2024-01-23","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":97236},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671137,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":97236,"price":0.125,"value":12154.5,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."}],"balance_after":97236,"derivative":{"exercise_price":5.36,"exercise_date":"2024-01-23","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":97236},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671136,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":72338,"price":0.125,"value":9042.25,"ownership":{"direct":false,"nature":"By Sanderling Venture Partners VI Co-Investment Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."}],"balance_after":72338,"derivative":{"exercise_price":7.15,"exercise_date":"2024-01-23","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":72338},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671135,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":72338,"price":0.125,"value":9042.25,"ownership":{"direct":false,"nature":"By Sanderling Venture Partners VI Co-Investment Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."}],"balance_after":72338,"derivative":{"exercise_price":5.36,"exercise_date":"2024-01-23","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":72338},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671134,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":121678,"price":0.125,"value":15209.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter."}],"balance_after":121678,"derivative":{"exercise_price":7.15,"exercise_date":"2024-01-23","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":121678},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671133,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":121678,"price":0.125,"value":15209.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter."}],"balance_after":121678,"derivative":{"exercise_price":5.36,"exercise_date":"2024-01-23","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":121678},"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671132,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":28744,"price":3.702,"value":106410.288,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VII"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":30292,"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671131,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":3920,"price":3.702,"value":14511.84,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VI"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":21602,"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671130,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":13184,"price":3.702,"value":48807.168,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII Annex Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":27609,"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671129,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":51032,"price":3.702,"value":188920.464,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII (Canada), L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":114260,"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671128,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":194472,"price":3.702,"value":719935.344,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":435148,"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671127,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":144676,"price":3.702,"value":535590.552,"ownership":{"direct":false,"nature":"By Sanderling Venture Partners VI Co-Investment Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":727433,"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1671126,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":4,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":5,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":6,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":7,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T20:00:32.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":243356,"price":3.702,"value":900903.912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."}],"balance_after":946744,"source":{"system":"sec-edgar","filing":"0001415889-24-001830","document":"form4-01252024_080106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000141588924001830/form4-01252024_080106.xml","form_type":"4"}},{"id":1762841,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":167,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VII"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F27","text":"Received in exchange for a warrant to purchase 5,775 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":167,"derivative":{"exercise_price":27.94,"expiration_date":"2026-06-25","underlying":"Common Stock","underlying_shares":167},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762840,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":113,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VII"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F26","text":"Received in exchange for a warrant to purchase 3,915 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":113,"derivative":{"exercise_price":27.94,"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":113},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762839,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":840,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII Annex Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F25","text":"Received in exchange for a warrant to purchase 29,139 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":840,"derivative":{"exercise_price":27.94,"expiration_date":"2026-06-25","underlying":"Common Stock","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762838,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":569,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII Annex Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F24","text":"Received in exchange for a warrant to purchase 19,754 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":569,"derivative":{"exercise_price":27.94,"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":569},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762837,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":3249,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII (Canada), LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F23","text":"Received in exchange for a warrant to purchase 112,796 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":3249,"derivative":{"exercise_price":27.94,"expiration_date":"2026-06-25","underlying":"Common Stock","underlying_shares":3249},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762836,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":2203,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII (Canada), LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F22","text":"Received in exchange for a warrant to purchase 76,470 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":2203,"derivative":{"exercise_price":27.94,"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":2203},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762835,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":12380,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Received in exchange for a warrant to purchase 429,837 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":12380,"derivative":{"exercise_price":27.94,"expiration_date":"2026-06-25","underlying":"Common Stock","underlying_shares":12380},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762834,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":8393,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F20","text":"Received in exchange for a warrant to purchase 291,407 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":8393,"derivative":{"exercise_price":27.94,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":8393},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762833,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":183,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VI"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Received in exchange for a warrant to purchase 6,343 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":183,"derivative":{"exercise_price":27.94,"expiration_date":"2026-06-25","underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762832,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":237,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VI"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Received in exchange for a warrant to purchase 8,203 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":237,"derivative":{"exercise_price":27.94,"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":237},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762831,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":15403,"ownership":{"direct":false,"nature":"By Sanderling Venture Partners VI Co-Investment Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Received in exchange for a warrant to purchase 534,815 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":15403,"derivative":{"exercise_price":27.94,"expiration_date":"2026-06-25","underlying":"Common Stock","underlying_shares":15403},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762830,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":6852,"ownership":{"direct":false,"nature":"By Sanderling Venture Partners VI Co-Investment Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Received in exchange for a warrant to purchase 237,911 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":6852,"derivative":{"exercise_price":27.94,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":6852},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762829,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":1910,"ownership":{"direct":false,"nature":"By Sanderling Venture Partners VI Co-Investment Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Received in exchange for a warrant to purchase 66,305 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":1910,"derivative":{"exercise_price":26.74,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":1910},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762828,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":2685,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Received in exchange for a warrant to purchase 93,225 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":2685,"derivative":{"exercise_price":27.94,"expiration_date":"2026-06-25","underlying":"Common Stock","underlying_shares":2685},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762827,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":16539,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Received in exchange for a warrant to purchase 574,269 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":16539,"derivative":{"exercise_price":27.94,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":16539},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762826,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":2672,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Received in exchange for a warrant to purchase 92,748 shares of common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Immediately exercisable."}],"balance_after":2672,"derivative":{"exercise_price":26.74,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":2672},"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762825,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":1548,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VII"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Received in exchange for 53,733 shares of the common stock of CalciMedica pursuant to the Merger Agreement."}],"balance_after":1548,"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762824,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":63228,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII (Canada), L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Received in exchange for 2,195,354 shares of the common stock of CalciMedica pursuant to the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VII Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":63228,"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762823,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":14425,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII Annex Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in exchange for 500,854 shares of the common stock of CalciMedica pursuant to the Merger Agreement."}],"balance_after":14425,"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762822,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":240676,"ownership":{"direct":false,"nature":"By Sanderling Ventures VII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in exchange for 8,356,779 shares of the common stock of CalciMedica pursuant to the Merger Agreement."}],"balance_after":240676,"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762821,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":8884,"ownership":{"direct":false,"nature":"By Sanderling VI Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in exchange for 308,455 shares of the common stock of CalciMedica pursuant to the Merger Agreement."}],"balance_after":8884,"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762820,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":7456,"ownership":{"direct":false,"nature":"By Sanderling VI Beteligungs GmbH & Co KG"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in exchange for 258,883 shares of the common stock of CalciMedica pursuant to the Merger Agreement."}],"balance_after":7456,"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762819,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":17682,"ownership":{"direct":false,"nature":"By Sanderling Ventures Management VI"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for 613,943 shares of the common stock of CalciMedica pursuant to the Merger Agreement."}],"balance_after":17682,"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762818,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":582757,"ownership":{"direct":false,"nature":"By Sanderling Venture Partners VI Co-Investment Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for 20,234,606 shares of the common stock of CalciMedica pursuant to the Merger Agreement."}],"balance_after":582757,"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}},{"id":1762817,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":86308,"kind":"organization","name":"Sanderling Venture Partners VI LP","position":1,"cik":"0001306717","reported_name":"Sanderling Venture Partners VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86305,"kind":"organization","name":"Sanderling Venture Partners VI Co Investment Fund LP","position":2,"cik":"0001306695","reported_name":"Sanderling Venture Partners VI Co Investment Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86306,"kind":"organization","name":"Sanderling Ventures Management VI","position":3,"cik":"0001429588","reported_name":"Sanderling Ventures Management VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86307,"kind":"organization","name":"Sanderling VI Beteiligungs GmbH & Co KG","position":4,"cik":"0001429283","reported_name":"Sanderling VI Beteiligungs GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86309,"kind":"organization","name":"Sanderling VI Limited Partnership","position":5,"cik":"0001429282","reported_name":"Sanderling VI Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86310,"kind":"organization","name":"Sanderling Ventures VII, L.P.","position":6,"cik":"0001565862","reported_name":"Sanderling Ventures VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86312,"kind":"organization","name":"Sanderling Ventures VII Annex Fund, L.P.","position":7,"cik":"0001678656","reported_name":"Sanderling Ventures VII Annex Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86313,"kind":"organization","name":"Sanderling Ventures Management VII","position":8,"cik":"0001993457","reported_name":"Sanderling Ventures Management VII","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86311,"kind":"organization","name":"Sanderling Ventures VII (Canada), L.P.","position":9,"cik":"0001993660","reported_name":"Sanderling Ventures VII (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T16:15:11.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":703388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 24,423,158 shares of common stock of CalciMedica, Inc. (\"CalciMedica\") pursuant to an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the \"Merger\"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc."}],"balance_after":703388,"source":{"system":"sec-edgar","filing":"0001209191-23-052521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993660/000120919123052521/doc4.xml","form_type":"4"}}]}